Effect of the calcium channel antagonist nitrendipine on lipoprotein lipase and hepatic lipase in the normal rat

European Journal of Pharmacology

Volumn 351, Issue 3, 1998, Pages 357-361

  Marotta, Teodoro ^a,b   Bergö, Martin ^b   Olivecrona, Thomas ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Anti hypertensive drug; Atherosclerosis; Ca2+ channel antagonist; Hepatic lipase; Lipoprotein lipase; Nitrendipine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; NITRENDIPINE;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; INTRAGASTRIC DRUG ADMINISTRATION; LIPID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADIPOSE TISSUE; ANIMALS; CALCIUM CHANNEL BLOCKERS; ENZYME INDUCTION; LIPASE; LIPOPROTEIN LIPASE; LIVER; MALE; MUSCLE, SKELETAL; MYOCARDIUM; NITRENDIPINE; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031829624     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00322-7     Document Type: Article

References (29)

1. Assmann, G., 1988. The Prospective Cardiovascular Münster (PROCAM) Study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am. Heart J. 116, 1713-1724.
2. Beisiegel, U., 1996. New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis. Atherosclerosis 124, 1-8.
3. Bengtsson-Olivecrona, G., Olivecrona, T., 1992. Assay of lipoprotein lipase and hepatic lipase. In: Converse, C.A., Skinner, E.R. (Eds.), Lipoprotein Analysis. A Practical Approach. Oxford Univ. Press, Oxford, pp. 169-185.
4. Bergö, M., Olivecrona, G., Olivecrona, T., 1996. Forms of lipoprotein lipase in rat tissues. In adipose tissue the proportion of inactive lipase increases on fasting. Biochem. J. 313, 893-898.
5. Borensztajn, J., Robinson, D.S., 1970. The effect of fasting on the utilization of chylomicron triglyceride fatty acids in relation to clearing factor lipase (lipoprotein lipase) releasable by heparin in the perfused rat heart. J. Lipid Res. 11, 111-117.
6. Brinton, E.A., Eisenberg, S., Breslow, J.L., 1991. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 87, 536-544.
7. Fan, J., Wang, J., Bensadoun, A., Lauer, S.J., Dang, Q., Mahley, R.W., Taylor, J.M., 1994. Over-expression of hepatic lipase in transgenic rabbit leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA 91, 8724.
8. Howard, B.V., 1992. Obesity, lipoproteins, and heart disease. Proc. Soc. Exp. Biol. Med. 200, 202-205.
9. Karpe, F., Thornvall, P., Olivecrona, T., Steiner, G., Carlson, L.A., Hamsten, A., 1993. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis 98, 33-49.
10. Kasiske, B.L., Ma, J.Z., Kalil, R.S.N., Louis, T.A., 1995. Effects of antihypertensive therapy on serum lipids. Ann. Intern. Med. 122, 133-141.
11. 2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler. Thromb. 12, 814-823.
12. Botnia Study Group, Knudsen, P., Eriksson, J., Lahdenperä, S., Kahri, J., Groop, L., Taskinen, M.-R., 1995. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Diabetologia 38, 344-350.
13. Lechleitner, M., Miesenböck, G., Patsch, J.R., 1990. HDL cholesterol, triglycerides and coronary heart disease. Curr. Opin. Lipidol. 1, 330-333.
14. Lichtlen, P.R., Hugenholtz, P.G., Rafflenbeul, W., Hecker, H., Jost, S., Deckers, J.W., 1990. Retardation of angiographie progression of coronary heart disease by nifedipine. Lancet 335, 1109-1113.
15. Liu, G., Olivecrona, T., 1991. Pulse-chase study on lipoprotein lipase in perfused guinea pig hearts. Am. J. Physiol. 261, H2044-H2050.
16. Marotta, T., Ferrara, L.A., Pasanisi, F., Rubba, P., Iovine, C., Mancini, M., 1989. Enhancement of exogenous triglyceride removal following calcium entry blockade. Artery 16, 312-326.
17. Meyer, H., Scherling, D., Karl, W., 1983. Nitrendipine: identification and synthesis of main metabolites. Arzneim.-Forsch./Drug Res. 33, 1528-1534.
18. Munroe, P.B., Johnston, A., Duke, V.M., Daniel, H.I., Bouloux, P.M., Lawson, M., Caulfield, M.J., 1994. Investigation of lipoprotein lipase as a candidate gene for dyslipidaemic hypertension. J. Hum. Hypertension 8, 613-614.
19. Murphy, M.B., Sugrue, D., Trayner, I., Kaufman, S., Yashuhara, H., Dollery, C.T., Thompson, G.R., 1984. Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary heart disease. Br. Heart J. 51, 589-594.
20. Nie, N.H., Hull, C.H., Jenkins, J.G., Steinbrenner, K., Bent, D.H., 1975. Statistical package for social sciences, 2nd edn. McGraw-Hill, New York.
21. Olivecrona, G., Olivecrona, T., 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6, 291-305.
22. Reaven, G.M., 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
23. Rustan, A.C., Nossen, J.Ø., Blomhoff, J.P., Drevon, C.A., 1986. Release of hepatic lipase and very low density lipoprotein by cultured rat hepatocytes. Int. J. Biochem. 18, 909-916.
24. Stoepel, K., Heise, A., Kazda, S., 1981. Pharmacological studies of the antihypertensive effect of nitrendipine. Arzneim.-Forsch./Drug Res. 31, 2056-2061.
25. Thorn, J.A., Chamberlain, J.C., Alcolado, J.C., Oka, K., Chan, L., Stocks, J., Galton, D.J., 1990. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 85, 55-60.
26. Thurman, R.G., Apel, E.D., Lemasters, J.J., 1988. Protective effect of nitrendipine against hypoxia injury in perfused livers from ethanoltreated rats. J. Cardiovasc. Pharmacol. 12 (Suppl. 4), 113-116.
27. Weidmann, P., Uehlinger, D.E., Gerber, A., 1985. Antihypertensive treatment and serum lipoproteins. J. Hypertens. 3, 297-306.
28. Weinstein, D.B., Heider, J.G., 1989. Antiatherogenic properties of calcium antagonists. Am. J. Med. 86 (Suppl. 4A), 27-32.
29. 3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. J. Clin. Invest. 70, 209-212.